Speaker: Dr. Garth L. Nicolson, MD, PhD with current medical insights commentary by Elizabeth Lee Vliet MD and Major Mike Gary, CBRN officer.
Dr. Garth L. Nicolson is an American cell biologist and founder of The Institute for Molecular Medicine at California, where he serves as the president, chief scientific officer, and emeritus professor of molecular pathology. He is editor of the Journal of Clinical and Experimental Metastasis, and the Journal of Cellular Biochemistry. He is one of the most cited scientists in the world, having published over 600 medical and scientific peer-reviewed papers, edited over 14 books, and served on the editorial boards of 28 medical and scientific journals. With S.J. Singer, Nicolson published a paper titled “The fluid mosaic model of the structure of cell membranes” in 1972, which is now regarded as a classic paper in cell biology.
TruNAC N-ACETYL L-CYSTEINE
A source of the conditionally essential amino acid L-cysteine and a precursor to the tripeptide glutathione. NAC and glutathione support antioxidant and detoxification activity in the body.
Dr. Nicolson’s research has focused on cancer biology and cellular properties related to aging. He had invented a number of techniques in the study of cancer, and has five US patents. He was a Nobel Prize nominee in Cell Microbiology. In 2003 he introduced the practice of lipid replacement therapy into a scientific concept. He observed that the therapy had anti-aging effects, restorative potential for chronic muscle weakness (fatigue), and was beneficial to patients undergoing cancer treatments. Dr. Nicolson found that at the cellular and molecular levels the actual replacement of damaged cellular lipids with undamaged lipids helped to maintain proper structure and function of cellular structures, mainly cell membrane and organelle membranes (especially those of mitochondria), and this is important for maintaining stable cellular functions. During the outbreak of the Gulf War syndrome, he was the leading authority on the study of the cause, treatment and prevention of the disease. He was appointed Chairman of the Medical-Scientific Panel for the Persian Gulf War Veterans Conference. His suspicion that the bacterium that caused the disease was a product of biological warfare led to extensive scientific investigations on this issue. He served as an expert on Gulf War Syndrome to the United States House of Representatives. For his service he was conferred honorary Colonel of the US Army Special Forces and honorary US Navy SEAL.
